Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.

@article{MartnezRaga2013RiskOS,
  title={Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.},
  author={Jos{\'e} Mart{\'i}nez-Raga and Carlos C Knecht and N{\'e}stor Szerman and Maria Isabel Valera Martinez},
  journal={CNS drugs},
  year={2013},
  volume={27 1},
  pages={15-30}
}
Attention-deficit hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder characterized by persistent symptoms of inattention, hyperactivity and/or impulsivity. The proportion of patients diagnosed with ADHD receiving pharmacological treatments has increased enormously in recent years. Despite the well established efficacy and the good safety and tolerability profile, there is concern about the potential for rare but serious cardiovascular adverse events, as well as sudden… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 12 times over the past 90 days. VIEW TWEETS